ChromaDex Corporation Reports 2018 Financial Results
March 07, 2019 16:01 ET
|
ChromaDex Corporation
- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 ...
ChromaDex to Present at the 39th Annual Cowen Health Care Conference
March 01, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, March 01, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will present at...
ChromaDex to Report Fourth Quarter 2018 Financial Results on Thursday, March 7, 2019
February 28, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., Mar. 7, 2019 at 4:30 p.m. Eastern time to discuss its financial...
New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model
January 23, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported that results of a first-of-a-kind preclinical study on lactation have shown that supplementation with the...
ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health
January 22, 2019 16:05 ET
|
ChromaDex Corporation
LOS ANGELES, Jan. 22, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported the rejection of Elysium Health Inc.’s challenge to Claim 2 of U.S. Patent No. 8,383,086 ("the '086...
ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®
December 20, 2018 16:05 ET
|
ChromaDex Corporation
LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a license and supply agreement with Nestlé Health Science (NHSc), a global leader...
TRU NIAGEN® Expands North American Footprint with Product Launch in Canada
December 17, 2018 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Dec. 17, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it has officially launched TRU NIAGEN® in Canada, having received regulatory approval for sale by Health...
TRU NIAGEN® to be Featured at the American Academy of Anti-Aging Medicine Annual Meeting
December 12, 2018 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Dec. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it will feature TRU NIAGEN® (Booth #6095) at the American Academy of Anti-Aging Medicine World Congress,...
ChromaDex to Present at the 11th Annual LD Micro Main Event
November 28, 2018 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Nov. 28, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Co-Founder & Executive Chairman, Frank Jaksch, and Chief...
New TRU NIAGEN® Stick Packs Target New Audiences and Consumer Needs
November 20, 2018 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today the launch of TRU NIAGEN stick packs, offering a new delivery method of its revolutionary nicotinamide...